Abeona Therapeutics Inc

NASDAQ:ABEO   3:55:17 PM EDT
0.23
-0.01 (-3.21%)
Other Pre-Announcement

Abeona Therapeutics Inc - Expect To Begin 2022 With Cash And Financial Resources Of More Than $50 Million (Unaudited)

Published: 12/22/2021 12:49 GMT
Abeona Therapeutics Inc (ABEO) - Abeona Therapeutics Inc - Expect to Begin 2022 With Cash and Financial Resources of More Than $50 Million (unaudited).
Abeona Therapeutics Inc Sees Top-line Viital™ Study Results in Q3 of 2022.
Abeona Therapeutics Inc Sees Top-line Results for Mps Iiia Transpher a Study Between Q4 of 2022 and Q2 of 2023.
Abeona Therapeutics Inc Sees Two-year Neurocognitive Data From Mps Iiib Transpher B Study in Second Half of 2022.
Abeona Therapeutics - to Generate Proof-of-concept Data Assessing Aav Capsids in Multiple Undisclosed Eye Indications Beginning in First Half of 2022.
Abeona Therapeutics Inc Sees Pre-ind Meeting With FDA in Second Half of 2022.